Work

Corrigendum to “Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy” [Biomaterials 312 (2025) 122750

Year: 2024

Type: erratum

Source: Biomaterials

DOI: 10.1016/j.biomaterials.2024.122831

Authors: Mostafa Yazdimamaghani, Oleg V. Kolupaev, Chaemin Lim, Duhyeong Hwang, Sonia J. Laurie, Charles M. Perou, Alexander V. Kabanov, Jonathan S. Serody

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Duke University, CHA University, Keimyung University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,740

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1569999668, Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.

OpenAlex ID: W4402540667

Cites:

Cited by:

Related to: 10